New Amsterdam Link

: Reported $728.9 million in cash and equivalents as of December 31, 2025, a decrease from the previous year due to R&D spending .

A 2025 annual report for this investment firm was released on . Rental Income : Generated €18.5 million in 2025 . New Amsterdam

: Improved slightly to a net loss of $203.8 million for 2025, compared to $241.6 million in 2024 . : Reported $728

: Ongoing heavy investment in the development of obicetrapib . Finance: New Amsterdam Invest N.V. New Amsterdam

: Total investment property stood at €118.0 million at year-end .